Meta-analysis of association between the -2578C/A polymorphism of the vascular endothelial growth factor and retinopathy in type 2 diabetes in asians and caucasians

Ophthalmic Research

Volumn 52, Issue 1, 2014, Pages 1-8

  Wang, Hao ^a   Cheng, Jin Wei ^a   Zhu, Li Shuang ^b   Wei, Rui Li ^a,b   Cai, Ji Ping ^a   Li, You ^a   Ma, Xiao Ye ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; Polymorphism; Vascular endothelial growth factor

Indexed keywords

ARTICLE; ASIAN; CAUCASIAN; DIABETIC RETINOPATHY; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VASCULOTROPIN GENE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; FACTUAL DATABASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENOTYPE; REVIEW;

VASCULOTROPIN A; VEGFA PROTEIN, HUMAN; VASCULOTROPIN;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898674369     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000357110     Document Type: Article

References (49)

1. Congdom N, Friedman DS, Lietman T: Important causes of visual impairment in the world today. JAMA 2003; 290: 2057-2060.
2. Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP: Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009; 1: 8-13.
3. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, et al: Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008; 27: 331-371.
4. Wirostko B, Wong TY, Simo R: Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 2008; 27: 608-621.
5. Aiello LP, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl 2000; 77:S113-S119.
6. Duh E, Aiello LP: Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999; 48: 1899-1906.
7. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO: Vascular endothelial growth factor and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22: 1-29.
8. Boulton M, Foreman D, Williams G, McLeod D: VEGF localization in diabetic retinopathy. Br J Ophthalmol 1998; 82: 561-568.
9. Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, et al: Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41: 1649-1656.
10. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, et al: Suppression of retinal neovascularization in-vivo by inhibition of vascular endothelial growth-factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995; 92: 10457-10461.
11. Konopatskaya O, Churchill A, Harper S, Bates DO, Gardiner T: VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 2006; 12: 626-632.
12. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE: Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235.
13. Chun MY, Hwang HS, Cho HY, Chun HJ, Woo JT, et al: Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J Clin Endocrinol Metab 2010; 95: 3547-3551.
14. Abhary S, Burdon KP, Gupta A, Lake S, Selva D, et al: Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50: 5552-5558.
15. Nakamura S, Iwasaki N, Funatsu H, Kitano S, Iwamoto Y: Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247: 21-26.
16. Kangas-Kontio T, Vavuli S, Kakko SJ, Penna J, Savolainen ER, et al: Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol 2009; 93: 1401-1406.
17. Yang X, Deng Y, Gu H, Lim A, Altankhuyag A, et al: Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis 2011; 17: 3088-3096.
18. Bleda S, De Haro J, Varela C, Esparza L, Ferruelo A, et al: Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in type II diabetic patients. Diab Vasc Dis Res 2012; 9: 68-74.
19. Awata T, Kurihara S, Takata N, Neda T, Iizuka H, et al: Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 2005; 333: 679-685.
20. Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, et al, DCCT/EDIC Research Group: Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 2007; 56: 2161-2168.
21. Nakanishi K, Watanabe C: Single nucleotide polymorphisms of vascular endothelial growth factor gene intron 2 are markers for early progression of diabetic retinopathy in Japanese with type 1 diabetes. Clin Chim Acta 2009; 402: 171-175.
22. Munafo MR, Flint J: Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444.
23. Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2. Cochrane Collaboration, 2008. http://www.mrc-bsu. cam.ac.uk/cochrane/handbook/(accessed June 25, 2012).
24. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339:b2535.
25. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trial 1986; 7: 177-188.
26. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J: A method for meta-analysis of molecular association studies. Stat Med 2005; 9: 1291-1306.
27. Egger M, Davey SG, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
28. Caldwell RB, Bartoli M, Behzadian MA, et al: Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 2003; 19: 442-455.
29. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 1829-1839.
30. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, et al: Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 2005; 28: 1163-1168.
31. Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, et al: Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 2008; 49: 3839-3845.
32. Monti MC, Lonsdale JT, Montomoli C, Montross R, Schlag E, et al: Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab 2007; 92: 4650-4655.
33. Hietala K, Forsblom C, Summanen P, Groop PH: Heritability of proliferative diabetic retinopathy. Diabetes 2008; 57: 2176-2180.
34. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, et al: A common polymorphism in the 5-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 5: 1635-1639.
35. Frank RN: Vascular endothelial growth factor-its role in retinal vascular proliferation. N Engl J Med 1994; 331: 1519-1520.
36. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, et al: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487.
37. Takagi H, Watanabe D, Suzuma K, Kurimoto M, Suzuma I, et al: Novel role of erythropoietin in proliferative diabetic retinopathy. Diabetes Res Clin Pract 2007; 77(suppl 1):S62-S64.
38. Katsura Y, Okano T, Matsuno K, Osako M, Kure M, et al: Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 2005; 28: 2252-2254.
39. Tolentino MJ, Brucker AJ, Fosnot J, Ying GS, Wu IH, et al: Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina 2004; 24: 132-138.
40. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, et al: Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003; 9: 210-216.
41. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Siviridis E: VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004; 6: 293-298.
42. Howell WM, Ali SJ, Rose-Zerilli M, Ye S: VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005; 42: 485-490.
43. Del Bo R, Scarlato M, Ghezzi S, Martinelli B, Fenoglio C, Galbaiati S, et al: Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 2005; 57: 373-380.
44. Szeto CC, Chow KM, Poon P, Szeto CY, Wong TY, Li PK: Genetic polymorphism of VEGF: impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients. Kidney Int 2004; 63: 1947-1955.
45. Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al: Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260-264.
46. Jin Q, Hemminki K, Forsti A, et al: Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005; 1: 3647-3653.
47. Roberto DB, Marina S, Serena G, et al: VEGF gene variability and type 1 diabetes: evidence for a protective role. Immunogenetics 2006; 58: 107-112.
48. Zhao TF, Zhao JP: Association between the-634 C/G polymorphisms of the vascular endothelial growth factor and retinopathy in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2010; 90: 45-53.
49. Raman R, Biswas S, Gupta A, Kulothungan V, Sharma T: Association of macular pigment optical density with risk factors for wet agerelated macular degeneration in the Indian population. Eye (Lond) 2012; 26: 950-957.